Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice

Hiroshi Ueno, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yu Takahashi, Yousuke Matsumoto, Motoi Okamoto, Takeshi Ishihara

Research output: Contribution to journalArticle

Abstract

The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents to the brain remain major obstacles in the research and development of new therapeutic methods for brain disorders. Therefore, delivering existing therapeutic agents to the central nervous system is expected to provide benefits in various diseases. In this study, we investigated whether inhaled central nervous system drugs reached the brain and affected mouse behaviour. Dizocilpine (MK-801), which increases locomotor activity in mice, was mainly used to study this hypothesis. First, we administered MK-801, an N-methyl-D-aspartate receptor antagonist, to mice via inhalation and examined whether it induced excessive activity similar to that observed after intraperitoneal administration. We also examined the time- and dose-dependency of drug induced changes in mouse behaviour after MK-801 inhalation. Next, we investigated whether inhalation of scopolamine, pentobarbital, and imipramine also affected mouse behaviour. Mice that inhaled MK-801 showed MK-801–induced hyperactivity similar to that observed following intraperitoneal administration. Furthermore, the extent of activity changed in a time- and dose-dependent manner after MK-801 inhalation. Inhalation of pentobarbital, scopolamine, and imipramine also changed mouse behaviour. These results demonstrate that inhalation of MK-801 exerts effects similar to those achieved with intraperitoneal and oral administration in mice. Thus, central nervous system agonists can reach the brain efficiently via inhalation. This finding may facilitate the development of improved therapies for brain disorders.

Original languageEnglish
Article number109038
JournalBiomedicine and Pharmacotherapy
Volume117
DOIs
Publication statusPublished - Sep 1 2019

Fingerprint

Inhalation Exposure
Dizocilpine Maleate
Inhalation
Brain Diseases
Central Nervous System Agents
Scopolamine Hydrobromide
Imipramine
Pentobarbital
Brain
Therapeutics
Locomotion
N-Methyl-D-Aspartate Receptors
Oral Administration
Central Nervous System

Keywords

  • Dizocilpine
  • Drug
  • Inhalation
  • MK-801
  • Mouse
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ueno, H., Suemitsu, S., Murakami, S., Kitamura, N., Wani, K., Takahashi, Y., ... Ishihara, T. (2019). Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice. Biomedicine and Pharmacotherapy, 117, [109038]. https://doi.org/10.1016/j.biopha.2019.109038

Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice. / Ueno, Hiroshi; Suemitsu, Shunsuke; Murakami, Shinji; Kitamura, Naoya; Wani, Kenta; Takahashi, Yu; Matsumoto, Yousuke; Okamoto, Motoi; Ishihara, Takeshi.

In: Biomedicine and Pharmacotherapy, Vol. 117, 109038, 01.09.2019.

Research output: Contribution to journalArticle

Ueno, H, Suemitsu, S, Murakami, S, Kitamura, N, Wani, K, Takahashi, Y, Matsumoto, Y, Okamoto, M & Ishihara, T 2019, 'Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice', Biomedicine and Pharmacotherapy, vol. 117, 109038. https://doi.org/10.1016/j.biopha.2019.109038
Ueno, Hiroshi ; Suemitsu, Shunsuke ; Murakami, Shinji ; Kitamura, Naoya ; Wani, Kenta ; Takahashi, Yu ; Matsumoto, Yousuke ; Okamoto, Motoi ; Ishihara, Takeshi. / Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice. In: Biomedicine and Pharmacotherapy. 2019 ; Vol. 117.
@article{cc2b7214e5db4ac39e229a9205b64d7d,
title = "Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice",
abstract = "The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents to the brain remain major obstacles in the research and development of new therapeutic methods for brain disorders. Therefore, delivering existing therapeutic agents to the central nervous system is expected to provide benefits in various diseases. In this study, we investigated whether inhaled central nervous system drugs reached the brain and affected mouse behaviour. Dizocilpine (MK-801), which increases locomotor activity in mice, was mainly used to study this hypothesis. First, we administered MK-801, an N-methyl-D-aspartate receptor antagonist, to mice via inhalation and examined whether it induced excessive activity similar to that observed after intraperitoneal administration. We also examined the time- and dose-dependency of drug induced changes in mouse behaviour after MK-801 inhalation. Next, we investigated whether inhalation of scopolamine, pentobarbital, and imipramine also affected mouse behaviour. Mice that inhaled MK-801 showed MK-801–induced hyperactivity similar to that observed following intraperitoneal administration. Furthermore, the extent of activity changed in a time- and dose-dependent manner after MK-801 inhalation. Inhalation of pentobarbital, scopolamine, and imipramine also changed mouse behaviour. These results demonstrate that inhalation of MK-801 exerts effects similar to those achieved with intraperitoneal and oral administration in mice. Thus, central nervous system agonists can reach the brain efficiently via inhalation. This finding may facilitate the development of improved therapies for brain disorders.",
keywords = "Dizocilpine, Drug, Inhalation, MK-801, Mouse, Schizophrenia",
author = "Hiroshi Ueno and Shunsuke Suemitsu and Shinji Murakami and Naoya Kitamura and Kenta Wani and Yu Takahashi and Yousuke Matsumoto and Motoi Okamoto and Takeshi Ishihara",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.biopha.2019.109038",
language = "English",
volume = "117",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice

AU - Ueno, Hiroshi

AU - Suemitsu, Shunsuke

AU - Murakami, Shinji

AU - Kitamura, Naoya

AU - Wani, Kenta

AU - Takahashi, Yu

AU - Matsumoto, Yousuke

AU - Okamoto, Motoi

AU - Ishihara, Takeshi

PY - 2019/9/1

Y1 - 2019/9/1

N2 - The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents to the brain remain major obstacles in the research and development of new therapeutic methods for brain disorders. Therefore, delivering existing therapeutic agents to the central nervous system is expected to provide benefits in various diseases. In this study, we investigated whether inhaled central nervous system drugs reached the brain and affected mouse behaviour. Dizocilpine (MK-801), which increases locomotor activity in mice, was mainly used to study this hypothesis. First, we administered MK-801, an N-methyl-D-aspartate receptor antagonist, to mice via inhalation and examined whether it induced excessive activity similar to that observed after intraperitoneal administration. We also examined the time- and dose-dependency of drug induced changes in mouse behaviour after MK-801 inhalation. Next, we investigated whether inhalation of scopolamine, pentobarbital, and imipramine also affected mouse behaviour. Mice that inhaled MK-801 showed MK-801–induced hyperactivity similar to that observed following intraperitoneal administration. Furthermore, the extent of activity changed in a time- and dose-dependent manner after MK-801 inhalation. Inhalation of pentobarbital, scopolamine, and imipramine also changed mouse behaviour. These results demonstrate that inhalation of MK-801 exerts effects similar to those achieved with intraperitoneal and oral administration in mice. Thus, central nervous system agonists can reach the brain efficiently via inhalation. This finding may facilitate the development of improved therapies for brain disorders.

AB - The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents to the brain remain major obstacles in the research and development of new therapeutic methods for brain disorders. Therefore, delivering existing therapeutic agents to the central nervous system is expected to provide benefits in various diseases. In this study, we investigated whether inhaled central nervous system drugs reached the brain and affected mouse behaviour. Dizocilpine (MK-801), which increases locomotor activity in mice, was mainly used to study this hypothesis. First, we administered MK-801, an N-methyl-D-aspartate receptor antagonist, to mice via inhalation and examined whether it induced excessive activity similar to that observed after intraperitoneal administration. We also examined the time- and dose-dependency of drug induced changes in mouse behaviour after MK-801 inhalation. Next, we investigated whether inhalation of scopolamine, pentobarbital, and imipramine also affected mouse behaviour. Mice that inhaled MK-801 showed MK-801–induced hyperactivity similar to that observed following intraperitoneal administration. Furthermore, the extent of activity changed in a time- and dose-dependent manner after MK-801 inhalation. Inhalation of pentobarbital, scopolamine, and imipramine also changed mouse behaviour. These results demonstrate that inhalation of MK-801 exerts effects similar to those achieved with intraperitoneal and oral administration in mice. Thus, central nervous system agonists can reach the brain efficiently via inhalation. This finding may facilitate the development of improved therapies for brain disorders.

KW - Dizocilpine

KW - Drug

KW - Inhalation

KW - MK-801

KW - Mouse

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85066778109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066778109&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2019.109038

DO - 10.1016/j.biopha.2019.109038

M3 - Article

C2 - 31177060

AN - SCOPUS:85066778109

VL - 117

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

M1 - 109038

ER -